CUSIP: 03832V307
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,038,129
-
Share change
-
-487,906
-
Total reported value
-
$5,587,288
-
Price per share
-
$1.84
-
Number of holders
-
22
-
Value change
-
-$897,049
-
Number of buys
-
6
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 03832V307?
CUSIP 03832V307 identifies APRI - APRICUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2018
-
Previous quarter:
Q3 2017
Recent filing periods for CUSIP 03832V307:
Institutional Holders of APRICUS BIOSCIENCES INC - COM NEW (APRI) as of Q4 2017
As of 31 Dec 2017,
APRICUS BIOSCIENCES INC - COM NEW (APRI) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,038,129 shares.
The largest 10 holders included
Sarissa Capital Management LP, ARMISTICE CAPITAL, LLC, Vanguard Group Inc, Healthcare Value Capital, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, BRANDES INVESTMENT PARTNERS, LP, OxFORD Asset Management LLP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.